Company Name	    Transcend Therapeutics Inc
Nasdaq Stock symbol	     TSND.O
Estimated price range	   $12-$14/shr
Total shares to be offered    2 million
Shrs outstanding after ipo    5,749,126
Lead Underwriter    Vector Securities International Inc
Underwriters over-allotment  300,000 shrs Business: develops pharmaceuticals for treatment of diseases caused by oxidative stress and resultant tissue damage with a particular therapeutic focus on critical care. Use of Proceeds: to fund clinical trials, research development programs and for other general corporate purposes.
Financial Data in 000s:     1995		 1994
   - Revenue		    N/A		   N/A
   - Net Income (loss)    ($4,450)	   ($3,603)